Head and Neck Cancer

3:01
Is mobile symptom monitoring the way forward for patients receiving radiotherapy?
Susan Peterson
2:24
CYCORE: vital monitoring during radiotherapy for head and neck cancer reduces symptom burden
Susan Peterson
3:09
M7824: a promising novel antibody for HPV-associated cancers
James Gulley
3:04
A breakthrough for oral mucositis management with avisopasem manganese
Ezra Cohen
2:28
Palbociclib for platinum-resistant metastatic head and neck cancer
Douglas Adkins
2:53
Positive results for palbociclib/cetuximab therapy in head and neck cancer
Ezra Cohen
4:03
KEYNOTE-040: groundbreaking results for pembrolizumab in head and neck cancer
Ezra Cohen
3:08
Improved survival, toxicity & QoL with pembrolizumab in head and neck cancer
Kevin Harrington
2:51
MASTERKEY-232: T-VEC not the way forward in relapsed head and neck cancer
Kevin Harrington
4:04
Hyperprogressive disease in lung cancer
Benjamin Besse
3:10
The risks of radioactive iodine treatment in thyroid cancer
Remco Molenaar
1:59
Pembrolizumab in the treatment of head and neck cancer: is there more to the story?
Jean-Pascal Machiels
1:12
Immunotherapy: changing the landscape of cancer treatment
Jean-Pascal Machiels
2:14
Innovative approaches to the treatment of head and neck cancer
Jean-Pascal Machiels
3:35
Is there a use for anti-PDL-1 antibodies in recurrent head and neck cancer?
Ezra Cohen
2:38
Exciting results of the SCORES trial
Ezra Cohen
The content of VJOncology is intended for healthcare professionals